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Kainate is a potent neurotoxin known to induce
acute seizures. However, whether kainate receptors
(KARs) play any role in the pathophysiology of
temporal lobe epilepsy (TLE) is not known. In TLE,
recurrent mossy fiber (rMF) axons form abnormal
excitatory synapses onto other dentate granule cells
that operate via KARs. The present study explores
the pathophysiological implications of KARs in
generating recurrent seizures in chronic epilepsy. In
an in vitro model of TLE, seizure-like activity was
minimized in mice lacking the GluK2 subunit, which
is a main component of aberrant synaptic KARs at
rMF synapses. In vivo, the frequency of interictal
spikes and ictal discharges was strongly reduced in
GluK2/ mice or in the presence of a GluK2/GluK5
receptor antagonist. Our data show that aberrant
GluK2-containing KARs play a major role in the
chronic seizures that characterize TLE and thus
constitute a promising antiepileptic target.INTRODUCTION
Kainate (KA) has long been known to induce behavioral and elec-
trophysiological acute seizures reminiscent of those found in
patients with temporal lobe epilepsy (TLE) (Ben-Ari and Cossart,
2000; Vincent andMulle, 2009; Lerma andMarques, 2013). How-
ever, whether kainate receptors (KARs) activated by the endog-
enous agonist glutamate play any role in the etiology of TLE is yet
unknown (Vincent and Mulle, 2009; Lerma and Marques, 2013).
Indeed, previous studies addressing the role of KARs have been
restricted to pharmacologically induced acute epileptiform activ-
ities in naive animals (Mulle et al., 1998; Vissel et al., 2001; Smol-
ders et al., 2002; Khalilov et al., 2002). Therefore, the role of KARs
in chronic and recurrent seizures, which is a cardinal patholog-
ical feature of TLE, remains to be established. In animal models
of chronic epilepsy, as in human TLE, the hippocampus displaysmajor network reorganization (Coulter et al., 2002; Noebels et al.,
2010). In particular, sprouting of hippocampal mossy fibers
(Represa et al., 1989a; Sutula et al., 1989; Isokawa et al., 1993;
Franck et al., 1995; Okazaki et al., 1995) leads to the formation
of powerful recurrent excitatory circuits between dentate granule
cells (DGCs), which accounts for, in part, the enhanced ability of
the hippocampus to generate epileptiform activity in human
patients and animal models of TLE (Tauck and Nadler, 1985; Pa-
trylo and Dudek, 1998; Lynch and Sutula, 2000; Buckmaster
et al., 2002; Scharfman et al., 2003; Gabriel et al., 2004). At the
aberrant recurrent excitatory synapses in DGCs, mossy fiber in-
puts impinging on DGCs operate mostly via ectopic KARs and
drive synaptic events with abnormal long-lasting kinetics not
present in naive conditions (Epsztein et al., 2005, 2010; Artinian
et al., 2011). In keeping with this, an increased density of kainate
binding sites was reported in the dentate gyrus (DG) of epileptic
patients (Represa et al., 1989b). The present study explores the
pathophysiological implications of KARs in the generation of
chronic and recurrent seizures in TLE through the use of KAR-
subunit-deficient mice and selected pharmacological agents.
In an animal model of TLE, we observe a strong reduction of
both interictal and ictal activities in the DG recorded in vitro
and in vivo in mice lacking the GluK2 subunit (GluK2/), or
with the use of a pharmacological agent inhibiting GluK2/
GluK5 receptors. Therefore, we demonstrate that aberrant
GluK2-containing KARs at recurrent mossy fiber (rMF) synapses
play a major role in chronic seizures in TLE.
RESULTS
Removal of KARs Reduces Epileptiform Activity in the
DG in Organotypic Slices
In an attempt to elucidate the role of KARs in spontaneous
epileptiform discharges in the DG, we used organotypic hippo-
campal slice cultures treated with pilocarpine that display mossy
fiber sprouting and spontaneous epileptiform activity (Figures
1A–1C and S1A) (Zimmer and Ga¨hwiler, 1984; McBain et al.,
1989; Gutie´rrez and Heinemann, 1999; Thomas et al., 2005;
Dyhrfjeld-Johnsen et al., 2010; Grabs et al., 1994; Albus et al.,
2013). We observed a similar sprouting of rMFs in wild-typeCell Reports 8, 347–354, July 24, 2014 ª2014 The Authors 347
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Figure 1. Reduced Epileptiform Activity in the Dentate Gyrus of
Organotypic Slices from GluK2/ Mice and in Presence of KAR
Antagonists
(A) Synaptoporin (purple) shows similar mossy fiber sprouting in WT and
GluK2/ slices. Granule cell layer and pyramidal cell layer of the CA3 (Nissl, in
green) is indicated by the dotted line. Inset highlights mossy fiber sprouting
(arrow); scale bar, 50 mm H, hilus; G, granule cell layer; scale bar, 100 mm.
(B) Number of epileptiform activity recorded in WT and GluK2/ slices. ***p <
0.001 (n = 32 and n = 25 slices, respectively) and in the presence of 5 mM
UBP310 (*p < 0.05, n = 32 and n = 11) or 10 mMSYM2081 (*p < 0.05, n = 32 and
n = 10).
(C) Extracellular field recordings of epileptiform activity (ACSF containing 5mM
K+ and 5 mM gabazine) in DG from WT (top) and after band-pass filtering
(bottom) before (left) and after application of 5 mM UBP310 (middle) and in
GluK2/ slices (right).
(D) Time-frequency spectrograms using wavelet analysis of recurrent bursts
(RBs) in WT before and after application of UBP310 and in GluK2/ slices
from high-pass-filtered traces; field power is coded in color with red corre-
sponding to the highest power.
(E) Power spectrum analysis (left) of filtered RBs and maximum power in each
group (right). ***p < 0.001 (n = 32 inWT and n = 25 in GluK2/ slices), **p < 0.01
(n = 11 with UBP310) and *p < 0.05 (n = 9 with SYM2081). All statistical tests
were performed by Mann-Whitney U test. In this and following figures: error
bars = SEM. See also Figures S1–S3.
348 Cell Reports 8, 347–354, July 24, 2014 ª2014 The Authors(WT) (n = 32) and GluK2/ (n = 27) slices following incubation
with pilocarpine as revealed by synaptoporin (SPO) staining
(Grabs et al., 1994) (see Supplemental Experimental Procedures)
(optical density [OD]: 26.1 ± 2.9 inWT and 25.0 ± 3.0 in GluK2/,
p > 0.05, Figure 1A). We confirmed that DGCs (Figure S1B) in
organotypic slices from WT mice displayed evoked and minia-
ture slow excitatory postsynaptic currents (EPSCs) mediated
by KARs (EPSCKA) (see Experimental Procedures; Figures
S1C–S1E), as observed in chronically epileptic rodents but not
in naive animals (Epsztein et al., 2005, 2010; Artinian et al.,
2011). EPSCKA were absent in GluK2
/ slices highlighting the
role of GluK2 in aberrant synaptic transmission; the remaining
fast EPSCs were mediated by AMPARs (Figures S1D and
S1E). EPSCKA originated from rMF synapses because they
were strongly inhibited by the group II mGluR agonist DCGIV
(Feng et al., 2003; Epsztein et al., 2005) (Figures S1F and S1G).
Reliable stereotyped spontaneous interictal-like activity
(Sabolek et al., 2012) was recorded in cultured slices using extra-
cellular field recordings in 5 mM K+-containing ACSF and 5 mM
gabazine (Figures 1B and 1C). The interical-like activity con-
sisted of two distinct phases, the paroxysmal discharge (PD) fol-
lowed by a late phase containing recurrent bursts (RBs) (McBain
et al., 1989; Gutie´rrez and Heinemann, 1999; Thomas et al.,
2005; Dyhrfjeld-Johnsen et al., 2010) (Figure 1C). The number
of interictal-like events was markedly reduced in cultured slices
from GluK2/ mice in comparison with WT (events/min: 3.2 ±
0.4 in WT and 1.7 ± 0.3 in GluK2/) (Figure 1B). The interictal-
like activity nested pathological high-frequency oscillations
with a peak frequency at around 200 Hz (Figures 1D and 1E) in
keeping with previous observations (Bragin et al., 2004; Dyhrf-
jeld-Johnsen et al., 2010). Interictal-like activity was visualized
by high-pass filtering (Figure 1C) and by time-frequency spectro-
grams (Figure 1D). Analysis revealed a marked reduction of po-
wer during RBs in GluK2/ mice (Figures 1D and 1E) without
a significant effect on the PD phase (Figures S2A and S2B).
In slices from WT mice, the number of interictal-like events
was significantly reduced in the presence of SYM2081 a
broad-spectrum KAR inhibitor (Epsztein et al., 2005, 2010; Arti-
nian et al., 2011) (events/min: 1.69 ± 0.3 in SYM2081) or
UBP310, an antagonist of postsynaptic GluK2/GluK5 receptors
at rMF synapses (Pinheiro et al., 2013) (1.47 ± 0.4 in UBP310)
(Figures 1B and 1C). SYM2081 or UBP310 markedly decreased
the power of RBs (Figures 1D and 1E) without a significant effect
on the PD phase (Figures S2A and S2B). A similar reduction of
interictal-like activity was observed in the presence of UBP310
in slices in which cuts were made to isolate the DG (Figures
S2C–S2F) indicating that epileptiform activity originated from
and propagated within the DG itself. In support of a role of
GluK2, (1) there was no effect on interictal-like activity in the
presence of UBP310 in GluK2/ mice (p > 0.05, n = 7); (2) the
number of interictal-like activity was similar in slices from
GluK1/ andWTmice (p > 0.05, n = 6); (3) UBP310 was similarly
effective in reducing the number of interictal-like events in WT
and in GluK1/ mice (p > 0.05, n = 6). Moreover, application
of cyclothiazide (CTZ) to slow the decay kinetics of EPSCAMPA,
hence mimicking the kinetics of aberrant EPSCKA (Figure S3A),
restored the number of events and power of interictal-like activity
in DGCs of GluK2/ mice (Figures S3B–S3D). Therefore, slow
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Figure 2. rMF Network-Driven Bursts Are Reduced in the Dentate
Gyrus of GluK2/ Mice and by UBP310 in WT Mice
(A) Synaptoporin (purple) shows similar mossy fiber sprouting in pilocarpine-
treatedWT and GluK2/mice; granule cell (g) layer labeled with Nissl staining
(green); h, hilus; iml, inner molecular layer. Scale bar, 200 mm. Higher magni-
fication (right) highlights mossy fiber sprouting; scale bar, 50 mm.
(B and C) On the left, averaged EPSC (n = 10) evoked by stimulating in the inner
molecular layer of the dentate gyrus in the presence of 5 mM gabazine and
40 mM D-APV. In WT slices (B), note that GYKI53655-resistant EPSC (black,
30mM) is abolished by 5 mM UBP310 (gray).
(C) In GluK2/ slices, note that EPSC (black) is abolished by 30 mM
GYKI53655. On the right, EPSC amplitude before and after UBP310 in WT
slices (B,**p < 0.01 by Wilcoxon test, n = 9) or before and after GYKI53655 in
GluK2/ slices (C,***p < 0.001 by Wilcoxon test, n = 11).
(D) Illustration of a hippocampal slice depicting the experimental design used to
evoke rMFnetwork-drivenburstsbyantidromic stimulation (AS)ofmossyfibers.
(E) Local field potential (LFP) evoked in the presence of 6.5 mM K+ and 5 mM
gabazine showing an antidromic population spike (AD) followed by a burst (B)
in WT slices before and after 5 mM UBP310 or in GluK2/ slices.
(F) Mean coastline burst index in WT slices before and after UBP310 or in
GluK2/ slices. **p < 0.01, ***p < 0.001 by Mann-Whitney U test (n = 5–11
slices per group).EPSCs mediated by KARs containing GluK2 are key players in
interictal-like activity in this in vitro model of TLE.
Aberrant GluK2-Containing KARs Are Involved in
rMF Network-Driven Bursts in DG in Slices from Mice
with TLE
To test the role of KARs in an animal model of TLE, experiments
were performed in slices from pilocarpine-treated WT orGluK2/mice several months after the inaugurating status epi-
lepticus (see Experimental Procedures). Under these conditions,
similar sprouting of rMFs was observed in both WT (n = 33) and
GluK2/ (n = 25) mice (OD: 15.9 ± 1.1 in WT and 20.9 ± 3.9 in
GluK2/, p > 0.05, Figure 2A) but not in naive conditions (data
not shown) as revealed by SPO staining. Hence, the lack of
GluK2 does not affect the establishment of rMF connections in
the pilocarpine model of TLE. By stimulating in the inner third
of the molecular layer and thereby targeting rMFs, EPSCKA
were recorded in DGCs fromWTbut not GluK2/ slices (Figures
2B and 2C). EPSCKA originated from rMF synapses because they
were strongly inhibited by DCGIV (by 84%, p < 0.05, n = 7, data
not shown). Epileptiform activities were then evoked by anti-
dromic stimulation of the mossy fiber pathway in the CA3b
area while recording local field potentials in the DGC layer
(Patrylo and Dudek, 1998; Epsztein et al., 2005) (Figures 2D
and 2E). We observed that rMF- network-driven bursts were
strongly reduced (see Experimental Procedures) in WT mice in
the presence of UBP310, and in GluK2/ mice (Figures 2E
and 2F). Thus, KARs containing GluK2 play a major role in burst
activity driven by rMFs in the DG.
Interictal Spikes and Ictal Discharges Are Reduced in
the Absence of GluK2-Containing KARs In Vivo in Mice
with TLE
Interictal spikes (ISs) represent one of the best documented
biomarkers of epilepsy in patient and animal models of TLE (Sab-
olek et al., 2012). To test whether KARs are involved in ISs, local
field potential recordings were performed in DG in vivo on anes-
thetized naive and pilocarpine-treated mice. As previously
reported (Curia et al., 2008), WT epileptic mice displayed
numerous ISs (137.2 ± 27.9 ISs/min, Figures 3A and 3B) several
months after inaugurating status epilepticus, but this type of ac-
tivity was never observed in naive animals (n = 5). In GluK2/
mice, the number of ISs was strongly reduced by 84% (21.6 ±
7.5 ISs/min, Figures 3A and 3B) without a significant change in
IS amplitude (p > 0.05, n = 8, data not shown). Intraperitoneal in-
jection of UBP310 (60mg/kg) strongly reduced the number of ISs
(Figures 3C and 3D) in WT mice, but not in GluK2/mice (n = 3,
data not shown). Interestingly, we did not observe any significant
effect of UBP310 on the typical physiological slow oscillations
(1.5–2 Hz, Figures S4A–S4C) driven by glutamatergic cortical
synaptic inputs (Hahn et al., 2007). No significant effect on IS
number was observed with a lower dose of UBP310 (6 mg/kg,
p > 0.05, n = 6, data not shown) or with injection of vehicle (p >
0.05, n = 13, data not shown).
Ictal discharges, due to abnormal and long-lasting (tens of
seconds) hypersynchronous neuronal activity, constitute the
cardinal pathophysiological electroencephalographic (EEG)
activity in TLE. These spontaneous and recurrent ictal events
originate from limbic structures including the hippocampus and
lead to profound disabling clinical manifestations. Intra-
hippocampal EEG recordings were performed in the DG of freely
moving WT and GluK2/ pilocarpine-treated mice several
months after inaugurating status epilepticus. EEG was continu-
ously monitored for several days using a telemetric system (Fig-
ure 4A; see Experimental Procedures). WT mice displayed
numerous ictal discharges (9.6 ± 2.3 per day) lastingCell Reports 8, 347–354, July 24, 2014 ª2014 The Authors 349
A
Radiofrequency
Telemetric hippocampal 
EEG recording 
24h per day
Ictal activityB
Tonic phase Clonic phase
Receiver
transmitter
0
15
10
yad/eruzie
S
Gl
uK
2-
/-
W
TTotal number ofseizures: 248
GluK2-/-
WT
77.8%
22.2%
1
#la
minA
Hours
12 24 36 48 60 72 84 96
2
3
4
5
6
7
9
10
WT
GluK2-/-
0
8
D E
C
15
20
10
0
5
F
+ 
UB
P3
10
W
T
yad/eruzie
S
* * *
V
m
5 5 s
V
m
5 2 s
5
Figure 4. The Number of Ictal Discharges Is Decreased in GluK2/
Mice and by UBP310 in WT Mice
(A) Illustration of the experimental design used for telemetric EEG recordings
(4 days, 24 hr per day).
(B) Example of a typical ictal event recorded in dentate gyrus of GluK2/mice.
Note the tonic and clonic phases.
(C) Distribution of seizures over time (12 hr periods) for each WT and GluK2/
mouse.
(D) Pie chart showing the fraction of ictal events recorded in WT (n = 5) and
GluK2/ (n = 5) mice (193 and 55 ictal events in WT and GluK2/ mice,
respectively).
(E) Number of ictal events in WT (n = 5) and GluK2/mice (n = 5) per day. *p <
0.05 by Mann-Whitney U test.
(F) Number of ictal events before and during treatment with 60 mg/kg UBP310
(n = 5). **p < 0.01 by paired t test. See also Figure S4.
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Figure 3. The Number of Interictal Spikes Is Decreased in GluK2/
Mice and by UBP310 in WT Mice
(A) Local field potential (LFP) recordings performed in vivo in dentate gyrus of
pilocarpine-treated WT (top) and GluK2/ mice (bottom); the dashed line in-
dicates the threshold for Interictal Spikes (IS) detection. Right traces show
magnified interictal spikes (ISs).
(B) Number of ISs/min in WT (n = 14) and GluK2/ mice (n = 8). *p < 0.05 by
unpaired t test.
(C) LFP recordings performed in dentate gyrus of WT pilocarpine-treated mice
in the absence and presence of UBP310 (60 mg/kg injected intraperitoneally).
Right traces show magnified ISs.
(D) Number of ISs/min before (n = 6) and after 60 mg/kg UBP310 (n = 6). *p <
0.05 by Wilcoxon test. See also Figure S4.36.9 ± 1.8 s (n = 5) and including tonic and clonic phases (Fig-
ure 4B). These ictal events corresponded to the well-described
generalized tonic-clonic seizures with motor convulsions and
loss of postural control (data not shown). We observed a strong
reduction of the number of ictal events in GluK2/ mice (by
72%) (Figures 4C and 4E) without a significant change in their
duration (p > 0.05, Figures S4D and S4E). Moreover, intraperito-
neal injections of UBP310 (60 mg/kg, see Experimental Proce-
dures) in WT mice for 3 days significantly reduced the number
of ictal discharges (Figure 4F) without a significant change in their
duration (p > 0.05, n = 5). No effect was observedwith injection of
vehicle (n = 3, data not shown). Taken together, these experi-
ments demonstrate that aberrant GluK2-containing KARs play
a major role in the generation of both ISs and ictal discharges
in vivo in TLE.
DISCUSSION
The well-characterized convulsive effects of exogenous kainate
application are often confusedwith the physiological functions of
KARs activated by the endogenous ligand glutamate (Vincent
and Mulle, 2009; Lerma and Marques, 2013). It is well-estab-
lished that KARs are involved in major physiological functions
in the CNS (Contractor et al., 2011), but paradoxically whether350 Cell Reports 8, 347–354, July 24, 2014 ª2014 The AuthorsKAR activated by the endogenous agonist glutamate play any
role in the etiology of chronic epilepsy remains to be established
(Vincent and Mulle, 2009; Lerma and Marques, 2013). Previous
studies addressing the role of KARs have been restricted to
pharmacologically induced acute epileptiform activities in naive
animals (Mulle et al., 1998; Vissel et al., 2001; Smolders et al.,
2002; Khalilov et al., 2002). In TLE, DGCs operate via aberrant
KARs at rMF synapses not present in naive conditions (Epsztein
et al., 2005, 2010; Artinian et al., 2011). In keeping with this, an
increased density of kainate binding sites was previously re-
ported in DG of epileptic patients (Represa et al., 1989b). We
thus explored the pathophysiological implications of KARs in
chronic and spontaneous seizures in DG of mice, and we now
show that KARs play a major role in chronic and spontaneous in-
terictal and ictal discharges in TLE.
In the present study, several lines of evidence support the role
of KARs containing GluK2 in chronic epileptic activities. (1)
Spontaneous and recurrent interictal-like activity measured
in vitro was less frequent during application of SYM2081, or
UBP310, a GluK2/GluK5 antagonist (Pinheiro et al., 2013) as
well as in GluK2/ but not in GluK1/ mice. The power of
epileptiform activity was reduced to the same degree by the an-
tagonists and in slices from GluK2/ mice indicating the spe-
cific importance of GluK2; similar data were obtained in slices
with isolated DG confirming the key role of GluK2-containing
KARs in this area. The pharmacological conversion of EPSCAMPA
kinetics hence mimicking the slow kinetics of aberrant EPSCKA
restored interictal-like activity in GluK2/ slices. This implies
that the slow kinetics of EPSCKA is a key element in the genera-
tion of epileptiform activities presumably because this feature
eases temporal summation of EPSPs and neuronal firing (Arti-
nian et al., 2011). (2) Network-driven bursts evoked by anti-
dromic mossy fiber stimulation and recorded in the DG of slices
from chronic pilocarpine-treated mice were strongly reduced in
the absence of KARs. This result is a clear indication that KARs
are involved in the rMF network-driven activity in TLE. (3) In vivo
recordings revealed a drastic reduction of ISs and ictal dis-
charges in GluK2/ compared with WT mice. Accordingly,
UBP310, which blocks synaptic KARs at recurrent synapses in
the DG (Pinheiro et al., 2013) (this study), acts as an antiepileptic
agent reducing the frequency of ISs and ictal discharges in WT
mice.
At mossy fiber CA3 synapses, postsynaptic KARs that
mediate a small component of the EPSCwith slow kinetics (Cas-
tillo et al., 1997; Frerking et al., 1998; Bureau et al., 2000; Ben-Ari
andCossart, 2000; Epsztein et al., 2005) in part due to the acces-
sory Neto protein (Copits et al., 2011; Zhang et al., 2009; Copits
and Swanson, 2012) and comprise GluK2 (Mulle et al., 1998),
GluK5 (Contractor et al., 2001; Ruiz et al., 2005), and GluK4 (Fer-
nandes et al., 2009). At present, the subunit composition of KARs
at rMF synapses remains unknown. Nevertheless, we propose
that the reduced seizure activity in the presence of UBP310 or
in GluK2/ mice is likely due to an effect on postsynaptic
GluK2/GluK5 receptors because (1) both GluK2 and GluK5 sub-
units are expressed in the DG but not GluK1 (Bahn et al., 1994;
Bureau et al., 1999); (2) the presence of GluK5 critically depends
on that of GluK2 (Christensen et al., 2004; Ruiz et al., 2005),
providing a reasonable explanation why EPSCKA are not
observed in DGCs of GluK2/ mice; (3) UBP310 was originally
developed as a GluK1 and GluK3 antagonist (Dolman et al.,
2007; Perrais et al., 2009), but the observed effect of UBP310
on epileptic activity is likely not mediated by these subunits (Dol-
man et al., 2007; Perrais et al., 2009), because this compound is
ineffective in GluK2/mice and fully effective in GluK1/mice;
(4) UBP310 is effective on postsynaptic GluK2/GluK5 receptors,
but not on homomeric GluK2 receptors (Pinheiro et al., 2013),
blocking EPSCKA in epileptic mice and rats (Pinheiro et al.,
2013); and (5) presynaptic KARs that modulate glutamate
release at bothmossy fiber CA3 (Schmitz et al., 2001; Contractor
et al., 2001; Lauri et al., 2001; Sachidhanandam et al., 2009) and
at rMF-DGC synapses (Feng et al., 2003) are probably not
involved in the reduction of seizures by UBP310, because this
compound is not effective on presynaptic receptors. Synapticactivation of KARs can also decrease Ca2+-activated K+ currents
(IsAHP) via a metabotropic signaling pathway, leading to an
increase of excitability (Melyan et al., 2002; Fisahn et al., 2005;
Ruiz et al., 2005). In our experimental conditions, we could
hypothesize that antagonism of KARs by UBP310 could reduce
excitability by acting on IsAHP. This is unlikely because UBP310
inhibits the ionotropic function of KARs at mossy fiber CA3 syn-
apses without affecting their metabotropic action (Pinheiro et al.,
2013).
In human and animal models of epilepsy, interictal activities as
well as pathological high-frequency oscillations are a hallmark of
epilepsy and are used as biomarkers to diagnose the pathology
(Sabolek et al., 2012; Jefferys et al., 2012). Moreover, ictal
discharges constitute the cardinal pathophysiological EEG
manifestation of TLE leading to profound disabling clinical symp-
toms. Besides strategy to prevent development of epilepsy (Liu
et al., 2013), blockade of chronic and recurrent seizures is there-
fore one of the main challenges in the treatment of TLE, which
often displays pharmaco-resistant features. Over the past 30
years, several new antiepileptic drugs have been developed.
These clinically approved compounds display a spectrum of
mechanisms of action, with effects on both inhibitory and excit-
atory signaling (Lo¨scher and Schmidt, 2012). Perampanel, a
noncompetitive selective AMPA receptor antagonist, has been
recently shown to decrease seizure frequency in patients with re-
fractory focal epilepsy (Lo¨scher and Schmidt, 2012; Rogawski
and Hanada, 2013). This therapeutic compound, which is now
clinically available, is administered at low concentration in order
to avoid side effects and neurological impairment because it tar-
gets the predominant receptors responsible for excitatory neuro-
transmission in the brain (Lo¨scher and Schmidt, 2012; Rogawski
and Hanada, 2013). Our present work discloses an antiepileptic
strategy that specifically targets different receptors (KARs) and
fully spares AMPA receptor-mediated excitatory neurotransmis-
sion in TLE in the chronic phase of epilepsy. GluK2/GluK5 KARs
constitute amore restricted target, present at only a limited num-
ber of synaptic sites, compared with AMPARs that are present at
all excitatory synapses. In addition to the different type of target,
our results provide a clear rationale for a specific pathophy-
siological mechanism (KARs at aberrant recurrent mossy fiber
dentate granule cell synapses) in contrast to the broad action
of perampanel on excitatory glutamatergic transmission. All in
all, we show that aberrant GluK2-containing kainate receptors
contribute to chronic seizures in TLE, urging for the development
of an antiepileptic strategy targeting these KARs.EXPERIMENTAL PROCEDURES
All experiments were approved by the Institut National de la Sante´ et de la
Recherche Me´dicale (INSERM) animal care and use agreement (B-13-055-
19) and the European community council directive (2010/63/UE). Mice
(FVB/N background) had access to food andwater ad libitum andwere housed
under a 12-hr-light/dark cycle at 22C –24C. For detailed methods, see Sup-
plemental Experimental Procedures.
In Vivo and In Vitro Models of Temporal Lobe Epilepsy
Mouse: Male GluK2/ and WT mice (P60-80) were administered pilocarpine
subcutaneously (200-600 mg/kg) using a ramp protocol. Slice culture: P9-10
hippocampal/entorhinal cortex slices were prepared fromGluK2/, GluK1/Cell Reports 8, 347–354, July 24, 2014 ª2014 The Authors 351
and WT mice. Pilocarpine (0.5 mM) was added to the medium at 5 days in vitro
(DIV) and removed at 7 DIV; slices were utilized for experiments from 9 DIV to
11 DIV.
Electrophysiological Recordings and Analysis In Vitro
Transverse hippocampal slices were prepared from extracted hippocampi of
pilocarpine-treated GluK2/ and WT mice, at 5–9 months of age. Cultured
or acute slices were individually transferred to a recording chamber main-
tained at 30–32C and continuously perfused (2 ml/min) with oxygenated
normal or adapted ACSF containing 5 mM gabazine. Local field potential re-
cordings in cultured and acute slices were made in the granule cell layer of
the DG. Evoked synaptic transmission was achieved utilizing a bipolar NiCh
electrode. In organotypic slices, whole-cell voltage-clamp recordings of spon-
taneous EPSCs were recorded at 70 mV. To characterize the nature and
kinetic properties of fast and slow events, miniature EPSCs (mEPSCs) evoked
in Sr2+ conditions were recorded in DGCs from pilocarpine-treated GluK2/
and WT slices. Electrical stimulation was made in the molecular layer in the
continued presence of 5 mM gabazine and 40 mM D-APV. WT cultured slices
displayed slowly decaying spontaneous and mEPSCs mediated by KARs
(Epsztein et al., 2005) (Figures S1C–S1E). KAR-mediatedmEPSCswere insen-
sitive to the AMPAR antagonist GYKI53655 (15 mM) (Figure S1D) and abolished
in the presence of the broad-spectrum KAR antagonist SYM2081 (10 mM) (Ep-
sztein et al., 2005, 2010; Artinian et al., 2011) or 5 mMUBP310, a potent antag-
onist of KARs at mossy fiber CA3 synapses (Pinheiro et al., 2013). These
events were absent in GluK2/ slices (Figure S1D); the remaining fast EPSCs
were fully blocked by AMPAR antagonist GYKI53655 (15 mM) in GluK2/ sli-
ces (data not shown). Accordingly, mEPSCs recorded in WT slices in the pres-
ence of 5 mM UBP310 were fully blocked by 15 mM GYKI53655 (data not
shown). Therefore, in organotypic slices 15 mM GYKI53655 is fully effective
in abolishing AMPAR-mediated EPSCs. The frequency of ongoing excitatory
postsynaptic currents (EPSCs) was similar in DGCs from WT and GluK2/
slices in organotypic slice (p > 0.05, n = 5, data not shown) and in acute slices
(p > 0.05, n = 7, data not shown). In cultured slices, visual representation of
time-frequency spectrogram of local field potentials was made using Autosig-
nal software (Seasolve 1.7). In acute hippocampal slices, intensity of evoked
network-driven bursts was quantified using coastline index.
Electrophysiological Recordings and Analysis In Vivo
Naive wild-type (WT) and pilocarpine-treated WT or GluK2/ mice
(5–6 months old) were used for local field potentials or electroencephalo-
graphic (EEG) recordings in DG. UBP310 or vehicle (saline/10% DMSO) was
subsequently injected intraperitoneally.
Morphological Analysis
See Supplemental Experimental Procedures for recurrent mossy fiber staining
and quantification and for biocytin and Prox1 revelation of DGCs.
Statistics Analyses
All values are given as means ± SEM. Statistical analyses were performed
using GraphPad Prism (GraphPad software 5.01).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.06.032.
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